Hydropothecary (THCX) News Today → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free THCX Stock Alerts C$5.30 +0.33 (+6.64%) (As of 06/21/2018) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)finance.yahoo.com - April 16 at 12:57 PMThe Hydropothecary Corporation (HEXO.TO)uk.finance.yahoo.com - February 25 at 4:25 PMAXS Cannabis ETF (THCX)finance.yahoo.com - February 17 at 8:47 AMOutlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR Newswireprnewswire.com - August 16 at 6:15 PMThe Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 15 at 8:09 AMBedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.comgurufocus.com - August 3 at 12:23 PMOptimum Investment Advisors Bu - GuruFocus.comgurufocus.com - August 2 at 3:13 PMThe Week In Cannabis: Tilray's Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More - Markets Insidermarkets.businessinsider.com - July 30 at 6:26 PMBaldwin Brothers Inc Buys Marr - GuruFocus.comgurufocus.com - July 30 at 1:25 PM Get Hydropothecary News Delivered to You Automatically Sign up to receive the latest news and ratings for THCX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results. Don't miss out on the "next Ozempic" >>> THCX Media Mentions By Week THCX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THCX News Sentiment▼0.000.43▲Average Medical News Sentiment THCX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THCX Articles This Week▼00▲THCX Articles Average Week Get Hydropothecary News Delivered to You Automatically Sign up to receive the latest news and ratings for THCX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACB News GUD News CRON News OGI News WEED News TLRY News SIA News WELL News NBLY News DNTL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:THCX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Hydropothecary Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
